• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Canatu H1'26 preview: Waiting for new reactor orders

CANATUAnalyst Comment2026-08-18 09:57
Atte RiikolaAnalyst
Discuss

Summary

  • Canatu's H1 revenue is expected to grow by 16% to 8.5 MEUR, driven by the semiconductor sector and the Robotics, Mobility and Defense segment, despite the absence of new reactor orders.
  • The company's adjusted EBIT for H1 is estimated at -8.3 MEUR, reflecting significant investments in organizational strengthening and production capacity expansion, including a new factory and inspection system.
  • Key focus areas include securing at least one new reactor order and finalizing customer approvals for the second reactor, with the new CEO's comments being closely monitored for strategic insights.
  • Canatu's 2026 revenue is forecasted to grow by 40% to 21.8 MEUR, although EBITDA is expected to remain negative at -11.5 MEUR due to ongoing cost structure growth.

This content is generated by AI. You can give feedback on it in the Inderes forum.

Estimates H1'25 H1'26 H1'26e H1'26e 2026e
MEUR/EUR Comparison Actualized Inderes Consensus Inderes
Revenue 7.3   8.5   21.8
EBITDA -4.1   -6.9   -11.5
EBIT (adj.) -4.9   -8.3   -14.4
EPS (reported) -0.12   -0.18   -0.32
           
Revenue growth-% -34.1%   16.4%   39.8%
EBIT-% (adj.) -66.5%   -97.8%   -65.9%

Source: Inderes

Translation: Original published in Finnish on 8/18/2026 at 7:05 am EEST.

Canatu will publish its H1 report on Tuesday, August 25, at 9:00 am EEST. We expect the company's revenue to have grown moderately from the comparison period, driven by both the semiconductor sector and the Robotics, Mobility and Defense segment (formerly Automotive Industry). We expect the result to have remained clearly in the red due to the company's front-loaded growth investments and still low revenue level. In the report, our attention is particularly drawn to the progress of the reactor business, as the company has not yet announced the one new reactor order targeted for this year. We will also be monitoring the new CEO's initial comments and the status of customer approvals for the second reactor customer. Canatu's extensive report, published in April, can be read here.

Moderate revenue growth in absolute terms is expected

We forecast Canatu's H1 revenue to have grown by 16% to 8.5 MEUR. We expect Semiconductor Industry revenue to have increased by 6% to 6.1 MEUR from the comparison period, which also did not include new reactor orders. In March, the company announced a follow-up order (1-2 MEUR) for long lead-time components from its current reactor customer (our assumption is FST), which supports revenue development. Sales of inspection membranes also provide the company with steady revenue, but precise visibility into Canatu's revenue development is weak. We estimate that the Robotics, Mobility and Defense segment's revenue grew by 53% to 2.4 MEUR, supported by ongoing development projects, such as the collaboration with DENSO. We do not expect revenue from Medical Diagnostics, as this business area is still in an early development phase and the launch of the first commercial product is planned for the end of the decade.

We expect earnings to still be clearly in the red

We estimate Canatu's adjusted EBIT for H1 to have been -8.3 MEUR (H1'25: -4.9 MEUR), Canatu's cost structure is largely fixed, and in recent years, the company has made significant investments to strengthen its organization and expand its production capacity. For example, the construction of the second factory in Vantaa and investments in the PELMIS inspection system increase depreciation and expenses. Scaling earnings and turning profitable requires significant growth in reactor business volumes in the coming years. Canatu's strong balance sheet enables investments, as its net cash position was still 90 MEUR at the end of H2'25.

Focus on reactor deals and comments from the new CEO

Canatu has not provided numerical guidance for the 2026 financial year, as the outcome and timing of ongoing customer negotiations significantly impact the company's short-term revenue development. In addition, the timeline for customer acceptance (SAT) of the second CNT100 SEMI reactor depends on the customer's processes. However, the company has provided a list of key operational targets for this year. The most important of these are to sell at least one new reactor to the semiconductor sector and to finalize customer approvals for the second reactor customer during this year. In the report, our interest is particularly focused on these matters. The report is also the first for the new CEO, Maximilian Slawinski, who started in May, so we will be following his comments with interest after a few months of familiarization. We currently forecast Canatu's 2026 revenue to grow to 21.8 MEUR (+40%), supported by one new reactor order. At the same time, we expect Canatu's cost structure to continue to grow, which will result in EBITDA (2026e -11.5 MEUR) remaining clearly in the red.

The market environment appears favorable for Canatu's longer-term growth. ASML, a key player in the industry, reported significantly stronger-than-expected Q2 results in July and substantially raised its full-year guidance, driven by AI investments. ASML's plans to aggressively increase its EUV capacity in 2027–2028 create excellent conditions for the growth of Canatu's target market, as the proliferation of the most advanced EUV systems is a key driver for the demand for the company's CNT pellicles.

 

Canatu is a technology company active in deep technology that creates carbon nanotubes (Canatu CNT), related products and manufacturing equipment for the semiconductor, automotive and medical diagnostics industries. The company operates through two business models, firstly using their own reactors to develop and manufacture CNT products. Second, the company sells its CNT reactors and licenses its related technology, allowing customers to produce the products themselves under a limited license.

Read more on company page

Key Estimate Figures17/08

202526e27e
Revenue15.621.848.7
growth-%-29.2 %39.8 %123.1 %
EBIT (adj.)-10.2-14.41.2
EBIT-% (adj.)-65.5 %-65.9 %2.5 %
EPS (adj.)-0.27-0.310.05
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.138.0
EV/EBITDAneg.neg.34.2

Forum discussions

Here are Ate’s pre-commentary notes ahead of Canatu reporting its H1 results next Tuesday We expect the company’s revenue to have grown modestly...
4 hours ago
by Sijoittaja-alokas
5
I’m 99% sure there’s no drama behind Gäddan’s departure. My guess is that he’s being drawn back to the previous firm where he worked for a very...
yesterday
by Palmu
1
I doubt there’s any drama there. They mention themselves that they are starting in a new place soon and believe in the success of Canatu. You...
8/15/2026, 3:13 PM
by PaulKo
8
What exactly is going on over there? Furthermore, 2030 is a very long time for Medical Diagnostics to wait for cash flow. Additionally, a startup...
8/15/2026, 3:06 PM
by Seeras
3
Thomas Gädda has resigned from the leadership of the semiconductor business unit. Turnover is high right now. LinkedIn Yesterday, I turned in...
8/15/2026, 11:15 AM
4
More on the data points from Veeco’s report: Veeco manufactures ion beam deposition equipment needed for the production of blank reticles. "...
8/13/2026, 10:41 AM
by Pandakarhu
10
Record Results for Norway’s Oil Fund – Here Is How Finnish Investments Fared The Norwegian oil fund significantly reduced its stake in Nordea...
8/13/2026, 7:10 AM
by Index
25